MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Prasugrel

CAS No. : 150322-43-3

MCE 站：Prasugrel

产品活性：Prasugrel，一种噻吩吡啶和前药，抑制血小板功能。Prasugrel 是一种具有口服活性的，有效的 P2Y12 受体拮抗剂，抑制 ADP 诱导的血小板聚集。

研究领域：GPCR/G Protein

作用靶点：P2Y Receptor

In Vivo: In rat platelets, Prasugrel active metabolite inhibits in vitro platelet aggregation induced by adenosine ADP (10μM) with an IC₅₀ value of 1.8 μM.
Prasugrel acts faster and is significantly more potent than Clopidogrel in vivo. Prasugrel is an inactive prodrug that requires metabolic processing in vivo to generate the active antiplatelet metabolite. Prasugrel is rapidly absorbed from the gut. After oral administration of standard-loading doses of 60 mg, maximum plasma levels of the active metabolite are achieved within 1 h, effective, maximum inhibition of platelet aggregation at 1-2 h.

相关产品：Covalent Screening Library Plus  |  Drug Repurposing Compound Library Plus  |  FDA-Approved Drug Library Plus  |  Bioactive Compound Library Plus  |  GPCR/G Protein Compound Library  |  FDA-Approved Drug Library  |  Peptidomimetic Library  |  Drug Repurposing Compound Library  |  Covalent Screening Library  |  Anti-Cardiovascular Disease Compound Library  |  Orally Active Compound Library  |  Neurotransmitter Receptor Compound Library  |  FDA Approved & Pharmacopeial Drug Library  |  Drug-Induced Liver Injury (DILI) Compound Library  |  Diquafosol tetrasodium  |  Ticagrelor  |  Clopidogrel hydrogen sulfate  |  Uridine 5′-diphosphoglucose disodium salt  |  YM-254890  |  MRS 2578  |  Uridine-5'-diphosphate disodium salt  |  BPTU  |  Cangrelor tetrasodium  |  AZD1283  |  Prasugrel hydrochloride  |  2-Methylthioadenosine diphosphate trisodium  |  Adenosine 2',5'-diphosphate sodium  |  MRS2279  |  MRS2500 tetraammonium  |  MRS2698  |  NF157  |  NF546  |  trans-R-138727MP  |  Denufosol tetrasodium  |  TAK-024

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。